1502655-48-2 Usage
General Description
Ledipasvir diacetone is a chemical compound that is most commonly used in the treatment of chronic hepatitis C virus (HCV) infections. It is a potent inhibitor of the NS5A protein, which plays a crucial role in the replication of the HCV virus. Ledipasvir diacetone works by interfering with the assembly of new viral particles and ultimately helps to suppress viral replication within the body. Ledipasvir diacetone is typically administered in combination with other antiviral medications to increase its effectiveness in treating HCV infections. Ledipasvir diacetone has shown promising results in clinical trials, demonstrating high rates of sustained virologic response and improved liver function in patients with chronic HCV infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1502655-48-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,0,2,6,5 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1502655-48:
(9*1)+(8*5)+(7*0)+(6*2)+(5*6)+(4*5)+(3*5)+(2*4)+(1*8)=142
142 % 10 = 2
So 1502655-48-2 is a valid CAS Registry Number.
1502655-48-2Relevant articles and documents
SOLID FORMS OF AN ANTIVIRAL COMPOUND
-
Paragraph 0263-0264, (2014/01/07)
Amorphous and crystalline solid forms of the anti-HCV compound (1-{3-[6-(9,9-difluoro-7-{2-[5-(2-methoxycarbonylamino-3-methyl-butyryl)-5-aza-spiro[2.4]hept-6-yl]-3H-imidazol-4-yl}-9H-fluoren-2-yl)-1H-benzoimidazol-2-yl]-2-aza-bicyclo[2.2.1]heptane-2-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester (Compound I) were prepared and characterized in the solid state: Also provided are processes of manufacture and methods of using the amorphous and crystalline forms.
